↓ Skip to main content

Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective study

Overview of attention for article published in Arthritis Research & Therapy, April 2016
Altmetric Badge

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
45 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective study
Published in
Arthritis Research & Therapy, April 2016
DOI 10.1186/s13075-016-0995-0
Pubmed ID
Authors

Bobby Kwanghoon Han, Igor Kuzin, John P. Gaughan, Nancy J. Olsen, Andrea Bottaro

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Unknown 44 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 13%
Researcher 6 13%
Professor 5 11%
Other 4 9%
Student > Master 4 9%
Other 7 16%
Unknown 13 29%
Readers by discipline Count As %
Medicine and Dentistry 16 36%
Immunology and Microbiology 7 16%
Biochemistry, Genetics and Molecular Biology 4 9%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Agricultural and Biological Sciences 1 2%
Other 2 4%
Unknown 13 29%